Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript

Outline

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Authors

Seyed Moayed Alavian1,*, Masoud Ahmadzad Asl2, maryam keshvari3, Bita Behnava4, bashir hajibeigi5
1Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
2Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
3Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
4Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
5Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
*Corresponding Author: Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran Email: [email protected]
Hepatitis Monthly:Vol. 6, issue 1; e92946
Published online:Mar 31, 2006
Article type:Research Article
Received:May 05, 2019
Accepted:Mar 31, 2006
How to Cite:Alavian SM, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. doi:
KeywordsChronic Hepatitis CInterferon αRibavirinIranTreatmentAdverse Drug Effects

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
May
2004

Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

Seyed Moayed Alavian,
Ali Kabir,
Behzad Hajarizadeh,
Mohsen Nayebpour Pharm,
bashir hajibeigi,
Taher Doroudi
,et al.
PDF

Alavian SM, Kabir A, Hajarizadeh B, Nayebpour Pharm M, hajibeigi B, et al. Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C. Hepat Mon. 2004;4(6):e92940. doi:

1
Jan
2006

Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study

SM Alavian,
A Kabir,
B Hajarizadeh,
M Nayebpour,
T Dorodi,
FE Baralle
PDF

Alavian S, Kabir A, Hajarizadeh B, Nayebpour M, Dorodi T, et al. Preliminary Report of Interferon ?2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C: a Quasi-Experimental Study. Shiraz E-Med J. 2006;7(1):20390. doi:

30
Sep
2004

The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial

Nasser Ebrahimi Daryani,
Babak Haghpanah,
Ali Reza Sayyah,
Ali Asad Hashtroudi,
Mohammad Bashashati,
Parisa Poursamimi
,et al.
PDF

Daryani N, Haghpanah B, Sayyah A, Hashtroudi A, Bashashati M, et al. The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial. Hepat Mon. 2004;4(7):. doi:

30
Sep
2004

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Moayed Alavian,
Behzad Hajarizadeh,
Bashir Hajibeigi,
Taher Doroudi,
Amir Kambiz Hamadanizadeh,
Koroush Abar
PDF

Alavian S, Hajarizadeh B, Hajibeigi B, Doroudi T, Hamadanizadeh A, et al. Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian. Hepat Mon. 2004;4(7):. doi:

31
May
2004

Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report

Shahnaz Sali,
Masoud Ahmadzad Asl,
Seyed Moayed Alavian,
Shahnaz Sali,
Masoud Ahmadzad Asl,
Seyed Moayed Alavian
PDF

Sali S, Ahmadzad Asl M, Alavian SM, Sali S, Ahmadzad Asl M, et al. Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report. Hepat Mon. 2004;4(6):e92938. doi:

More by these authors

Seyed Moayed AlavianPubMedScholar
Masoud Ahmadzad AslPubMedScholar
maryam keshvariPubMedScholar
Bita BehnavaPubMedScholar
bashir hajibeigiPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF297.43 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0